↓ Skip to main content

What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?

Overview of attention for article published in Frontiers in Pharmacology, April 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?
Published in
Frontiers in Pharmacology, April 2022
DOI 10.3389/fphar.2022.883987
Pubmed ID
Authors

Clémence Lacroix, Isabelle Alleman-Brimault, Arnaud Zalta, Frank Rouby, Catherine Cassé-Perrot, Elisabeth Jouve, Laurence Attolini, Romain Guilhaumou, Joëlle Micallef, Olivier Blin

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 15%
Student > Master 3 9%
Student > Ph. D. Student 3 9%
Student > Doctoral Student 1 3%
Student > Bachelor 1 3%
Other 5 15%
Unknown 16 47%
Readers by discipline Count As %
Medicine and Dentistry 5 15%
Biochemistry, Genetics and Molecular Biology 4 12%
Nursing and Health Professions 2 6%
Social Sciences 2 6%
Computer Science 1 3%
Other 3 9%
Unknown 17 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2023.
All research outputs
#13,908,131
of 23,578,918 outputs
Outputs from Frontiers in Pharmacology
#4,340
of 17,200 outputs
Outputs of similar age
#192,196
of 444,470 outputs
Outputs of similar age from Frontiers in Pharmacology
#236
of 1,225 outputs
Altmetric has tracked 23,578,918 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 17,200 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,470 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 1,225 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.